Erratum: METNET: a phase II trial of metformin in patients with well-differentiated neuroendocrine tumours

João Glasberg1,2, Aley Talans3,4, Thomás Rivelli Giollo1

  • 1Department of Clinical Oncology, Instituto do Câncer do Estado de São Paulo, Faculdade de Medicina da Universidade de São Paulo - FMUSP, São Paulo, Brazil.

Ecancermedicalscience
|September 26, 2022
PubMed